Altimetrik, a business transformation and technology solutions company is unveiling advanced IoT solutions that are set to revolutionize the manufacturing industry.
Manufacturing industry is faced with the challenge of digitally connecting its assets with systems and people, engineering and acting upon the data on the floor to achieve predictive maintenance, precision monitoring & remote management. Altimetrik's Enterprise IoT capabilities make operational intelligence real by connecting machine data to newer business insights & driving meaningful outcomes. Altimetrik has made significant investments in creating IoT specific Research & Innovation Labs which’ve helped the company become a frontrunner in IoT consulting and execution. Altimetrik has been identified among leading IoT solution providers for manufacturing by IDC
Altimetrik is among the new breed of technology companies driving its business model based on the three global mega trends of modernization – Digital, Connected Solutions and Consumer Technologies.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7772051-altimetrik-future-of-enterprise-internet/
Daimler AG, Ford Motor Company and Nissan Motor Co., Ltd., have signed a unique three-way agreement to accelerate the commercialization of fuel cell electric vehicle (FCEV) technology.
The goal of the collaboration is to jointly develop a common fuel cell electric vehicle system while reducing investment costs associated with the engineering of the technology. Each company will invest equally towards the project. The strategy to maximize design commonality, leverage volume and derive efficiencies through economies of scale will help to launch the world’s first affordable, mass-market FCEVs as early as 2017.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58680-renault-nissan-daimler-ford-partnership
A Princess of Roumania fantasy, with an extraordinary, intense, compressed SF novel in three parts, each set in its own alternate-history universe. The sections are all rooted in Virginia and the Battle of the Crater, and are also grounded in the real history of the Park family, from differing points of view.
The first section is set in the aftermath of the Civil War, in a world in which the Queen of the North has negotiated a two-nation settlement. The second, taking place in northwestern Massachusetts, investigates a secret project during World War II, in a time somewhat like the present. The third is set in the near-future United States, with aliens from history.
The cumulative effect is awesome. There hasn’t been a three part novel this ambitious in science fiction since Gene Wolfe’s classic The Fifth Head of Cerberus. Find out more at http://us.macmillan.com/allthosevanishedengines/PaulPark Fantasy/Scifi
Discover the monotriangolare, the new way of playing football. Three young promising football player, Santon, Paloschi and Pozzi, will compete in an epic game. Who will win? Who will be the future champion?
Intermopro, Intermeat and Intercool names that dont ring a bell with most
consumers. Nevertheless, they are very important. These three trade fairs of
the food industry showcase the latest developments in dairy, frozen food
cold meat and meat production. The market for bio-products continues to grow
non-stop. At the same time transparency regarding the origin of foodstuffs
becomes ever more important, not only for the consumer but even more so for
the producer.
Today marks the 87th anniversary of the Kingdom of Saudi Arabia. This day provides an opportunity to think about ways to give back to the nation, and there are many ways to give back to one’s country. One of these ways is to preserve the resources that the nation has, and at the forefront of these resources, is energy. It is the vein that Saudi Arabia feeds on to continue its development and prosperity.
For the past three years, the demand for energy increased at a yearly rate of 8%, and is expected to increase up to 58% in the next 25 years. These figures will have an immense impact on oil, especially that 90% of the Kingdom’s revenue is generated from oil exports. While 27% percent of the produced oil is spent on generating energy.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8184051-save-energy-saudi-national-day/
The Heart Rhythm Society (HRS), through its efforts during Atrial Fibrillation Awareness Month in September and throughout the year, is working to raise awareness of the increased prevalence of the disease and the associated risk of stroke in patients living with atrial fibrillation (AFib). Today, HRS releases a new public service announcement (PSA) as part of its ongoing work to educate Americans about AFib, the most common heart arrhythmia, and how it increases one’s risk of stroke fivefold. The PSA can be viewed by clicking here.
AFib affects more than three million Americans and it is estimated that 12 to 16 million Americans will have AFib by 2050. AFib occurs when the upper chambers of the heart (the atria) fibrillate, or “quiver,” which causes a rapid, irregular heart rhythm. The normal heart rate for an adult is between 60 and 100 beats every minute. When the heart is experiencing AFib, the atria can beat over 300 times every minute.
To view the multimedia release go to:
http://www.multivu.com/players/English/7312151-heart-rhythm-society-afib-stroke-psa/
In the United States for 2014, about 62,900 new thyroid cancer cases will be diagnosed. Medullary thyroid cancer – a rare form of cancer located in the thyroid gland at the base of the throat – represents only about three to four percent of all thyroid cancers. Of those cases, just one third will be locally advanced or metastatic disease. With Thyroid Cancer Awareness Month in full swing, AstraZeneca has launched the aMTCSupport.com online resource center to provide information and support specifically designed for people living with advanced medullary thyroid cancer (aMTC) and their loved ones.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7080731-astrazeneca-amtcsupport-resources-for-advanced-medullary-thyroid-cancer/
This is My Australia looks at the inspiring stories of recipient and nominees of the Australian Of The Year Awards. Channel 10, Friday Jan 17th at 7:30PM AFL great and community leader Adam Goodes is one of eight finalists for the prestigious Australian of the Year Award 2014. An
Andyamathanha man, Adam is a professional Australian Rules football
player with the Sydney Swans. He holds an elite place in AFL history,
winning two Brownlow Medals and two premierships. Adam is actively
involved with several Indigenous sport and community programs and as a
leader, speaks out against racism in sport and society. When
asked to identify three Australians that inspire him, Adam named his
mum, Lisa Sansbury, former coach Paul Roos and friend Michael
O'Loughlin.
VISTAKON®, Division of Johnson & Johnson Vision Care, Inc., and makers of ACUVUE® Brand Contact Lenses, today announced the “ACUVUE® 1•DAY Contest,” which will bring three lucky fans of singing star Charice a trip to Los Angeles to be featured in the music video for her new single, “One Day.”
Now through May 23, 2011, fans can enter the “ACUVUE® 1•DAY Contest” at www.facebook.com/ACUVUE for their chance to win one of the grand prizes, have their photos featured in Charice’s video, or one of the prize packages.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/acuvue/49745/
Representing the leading edge of a wave of new products and technologies, Acura today unveiled three new vehicles at the North American International Auto Show, including a concept version of the all-new gateway to the Acura brand, the ILX luxury compact sedan; a prototype of the 2013 RDX crossover sport utility vehicle; and the NSX Concept, which presages the direction for Acura’s next-generation supercar.
Acura also announced that the next-generation NSX will feature Acura’s innovative new Sport Hybrid SH-AWD® technology and that the vehicle will be developed by Honda R&D Americas and manufactured in Ohio.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/acura/45743/
Abbott announced today that the U.S. Food and Drug Administration has approved the company’s Absorb bioresorbable heart stent, making the first-of-its-kind medical device commercially available to treat people with coronary artery disease in the United States.
Absorb is the only fully dissolving stent approved for the treatment of coronary artery disease, which affects 15 million people in the United States and remains a leading cause of death worldwide, despite decades of therapeutic advances. While stents are traditionally made of metal, Abbott’s Absorb stent is made of a naturally dissolving material, similar to dissolving sutures. Absorb disappears completely in approximately three years, after it has done its job of keeping a clogged artery open and promoting healing of the treated artery segment. By contrast, metal stents are permanent implants that restrict vessel motion for the life of the person treated.
To view the multimedia release go to:
http://www.multivu.com/players/English/7826651-abbott-fda-approval-stent/
